EUVIMEDEUVIMED entdecken
Crossref

6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer

Joyann A Marks iD, Brittany L B Nichols, Laura I Mosquera-Giraldo, Sara T Yazdi, Lynne S Taylor iD, Kevin J Edgar iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Joyann A Marks und 5 weiteren Autor:innen. Beteiligte Einrichtung: Macromolecules Innovation Institute, Department of Sustainable Biomaterials, College of Natural Resources and Environment, Virginia Tech, Blacksburg,…. Hauptthemen laut MEDLINE: Solubility, Polymers, Cellulose, Ibuprofen. Die Arbeit nennt 67 Literaturangaben. Gefördert von: University of the West Indies, Virginia Polytechnic Institute and State University, Division of Materials Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amorphous solid dispersion (ASD) in a polymer matrix is a powerful method for enhancing the solubility and bioavailability of otherwise crystalline, poorly water-soluble drugs. 6-Carboxycellulose acetate butyrate (CCAB) is a relatively new commercial cellulose derivative that was introduced for use in waterborne coating applications. As CCAB is an amphiphilic, carboxyl-containing, high glass transition temperature (Tg) polymer, characteristics essential to excellent ASD polymer performance, we chose to explore its ASD potential. Structurally diverse drugs quercetin, ibuprofen, ritonavir, loratadine, and clarithromycin were dispersed in CCAB matrices. We evaluated the ability of CCAB to create ASDs with these drugs and its ability to provide solubility enhancement and effective drug release. CCAB/drug dispersions prepared by spray drying were amorphous up to 25 wt % drug, with loratadine remaining amorphous up to 50% drug. CCAB formulations with 10% drug proved effective at providing in vitro solubility enhancement for the crystalline flavonoid drug quercetin as well as ritonavir, but not for the more soluble APIs ibuprofen and clarithromycin and the more hydrophobic loratadine. CCAB did provide slow and controlled release of ibuprofen, offering a simple and promising Long-duration ibuprofen formulation. Formulation with clarithromycin showed the ability of the polymer to protect against degradation of the drug at stomach pH. Furthermore, CCAB ASDs with both loratadine and ibuprofen could be improved by the addition of the water-soluble polymer poly(vinylpyrrolidone) (PVP), with which CCAB shows good miscibility. CCAB provided solubility enhancement in some cases, and the slower drug release exhibited by CCAB, especially in the stomach, could be especially beneficial, for example, in formulations containing known stomach irritants like ibuprofen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SolubilityPolymersCelluloseIbuprofenLoratadineDrug LiberationQuercetinClarithromycinRitonavirChemistry, PharmaceuticalDrug Compounding

Stichwörter der Autor:innen

amorphous solid dispersioncarboxy cellulose esterloratadinesolubility enhancementstructural diversityternary blends

Substanzen

PolymersCelluloseIbuprofenLoratadineQuercetinClarithromycinRitonavircellulose acetate-butyrate

Autor:innen und Institutionen

  • Macromolecules Innovation Institute, Department of Sustainable Biomaterials, College of Natural Resources and Environment, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Department of Chemistry, University of the West Indies, Mona, Kingston JMAAW15, Jamaica.
  • Department of Chemistry, College of Science, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.

ORCID-Profile: Joyann A Marks, Lynne S Taylor, Kevin J Edgar

Förderung

  • University of the West Indies
  • Virginia Polytechnic Institute and State University
  • Division of Materials Research

Zitieren

APA

Marks, J. A., Nichols, B. L. B., Mosquera-Giraldo, L. I., T Yazdi, S., Taylor, L. S., & Edgar, K. J. (2024). 6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00493

Vancouver

Marks JA, Nichols BLB, Mosquera-Giraldo LI, T Yazdi S, Taylor LS, Edgar KJ. 6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00493

BibTeX
@article{Marks2024,
  author = {Marks, Joyann A and Nichols, Brittany L B and Mosquera-Giraldo, Laura I and T Yazdi, Sara and Taylor, Lynne S and Edgar, Kevin J},
  title = {6-Carboxycellulose Acetate Butyrate: Effectiveness as an Amorphous Solid Dispersion Polymer},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00493}
}
Kostenlos starten →